Summary
Combined treatment modality was applied in 110 consecutive women with primary inoperable (T3b-T4) breast cancer. Treatment was started with four cycles of adriamycin plus vincristine (AV). This was followed in responders by high-energy radiotherapy (RT). At the end of combined therapy, patients in complete remission (CR) were randomized to either no further treatment or six more cycles of chemotherapy. AV induced objective response in 89% of patients (complete 15.5%, partial 54.5%, improvement 19%). At the end of RT, 81 of 98 (82.7%) patients responding to AV were classified in CR. The median duration of CR was 15 months. The median free interval was statistically prolonged by additional chemotherapy. The three-year survival was 52.8%. Altogether, present findings indicate that combined treatment modality has improved the three-year survival compared to the previous series treated with radiotherapy alone. However, to achieve a satisfactory control of T3b-T4 breast cancer a more aggressive and prolonged treatment is required.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baclesse, F.: Roentgen therapy as sole method of treatment of cancer of breast. Amer. J. Roentgenol. 62, 331 (1949)
Band, P. R., Tormey, D. C., Bauer, R.: Induction chemotherapy and maintenance chemohormonotherapy in metastatic breast cancer. Proc. Amer. Ass. Cancer Res. 18 (Abstr. No. 911), 228 (1977)
Barker, J. L., Nelson, A. J., III, Montague, E. D.: Inflammatory carcinoma of the breast. Radiology 121, 173 (1976)
Brambilla, C., De Lena, M., Bonadonna, G.: Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma. Cancer Chemother. Rep. 58, 251 (1974)
Brambilla, C., De Lena, M., Rossi, A., Valagussa, P., Bonadonna, G.: Response and survival in advanced breast cancer after two non-cross resistant combinations. Brit. med. J. 1, 801 (1976)
Blumenschein, G. R., Gutterman, J. U., Landgren, R. C., Montague, E. D., Tashima, C. K.: Adriamycin combinations and radiation therapy for inflammatory breast cancer. Proc. Amer. Soc. clin. Oncol. 17 (Abstr. No. C-76), 255 (1976)
Chu, F. C. H., Nisce, L. Z., Baker, A. S., Sattar, S., Laughlin, J. S.: Electron-beam therapy of cancer of the breast. Radiology 89, 216 (1967)
De Lena, M., Brambilla, C., Morabito, A., Bonadonna, G.: Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate and 5-fluorouracil for advanced breast cancer. Cancer 35, 1108 (1975)
De Lena, M., De Palo, G. M., Bonadonna, G., Beretta, G., Bajetta, E.: Treatment of metastatic breast cancer with cyclophosphamide, methotrexate, vincristine and fluorouracil. Tumori 59, 11 (1973)
Edelman, A. H., Holtz, S., Powers, W. E.: Rapid radiotherapy for inoperable carcinoma of the breast. Benefits and complications. Amer. J. Roentgenol. 93, 585 (1965)
Fletcher, G. H.: Local results of the irradiation in the primary management of localized breast cancer. Cancer 29, 545 (1972)
Fletcher, G. H., Montague, E. D.: Radical irradiation of advanced breast cancer. Amer. J. Roentgenol. 93, 573 (1965)
Ghossein, N. A., Stacey, P., Alpert, S., Ager, P. J., Krishnaswamy, V.: Local control of breast cancer with tumorectomy plus radiotherapy or radiotherapy alone. Radiology 121, 455 (1976)
Levene, M. B., Harris, J. R., Hellman, S.: Treatment of carcinoma of the breast by radiation therapy. Cancer 39, 2840 (1977)
Mantel, N.: Ranking procedures for arbitrarily restricted observation. Biometrics 23, 65 (1967)
Montague, E. D.: Physical and clinical parameters in the management of advanced breast cancer with radiation therapy alone. Amer. J. Roentgenol. 99, 995 (1967)
Pierquin, B., Baillet, F., Wilson, J. F.: Radiation therapy in the management of primary breast cancer. Amer. J. Roentgenol. 127, 645 (1976)
Prosnitz, L. R., Goldenberg, I. S., Packard, R. A., Levene, M. B., Harry, J., Hellman, S., Wallner, P. E., Brady, L. W., Mansfield, C. M., Kramer, S.: Radiation therapy as initial treatment for early stage cancer of the breast without mastectomy. Cancer 39, 917 (1977)
Rojas, A. F., Mickiewicz, E., Feierstein, J. N., Glait, H., Olivari, A. J.: Levamisole in advanced human breast cancer. Lancet 1976 I, 211
Rubens, R. D., Armitage, P., Winter, P. J., Tong, D., Hayward, J. L.: Prognosis in inoperable stage III carcinoma of the breast. Europ. J. Cancer 13, 805 (1977)
Sponzo, R. W., Antemann, R., Mason, J., Cunningham, T. J.: Management of non-resectable (Stage III) breast carcinoma. Proc. Amer. Soc. clin. Oncol. 18 (Abstr. No. C-344), 352 (1977)
Weber, E., Hellman, S.: Radiation as primary treatment for local control of breast carcinoma. A progress report. J. Amer. med. Ass. 234, 608 (1975)
Zucali, R., Uslenghi, C., Kenda, R., Bonadonna, G.: Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer 37, 1422 (1976)
Author information
Authors and Affiliations
Additional information
Supported in part by Contract No. N01-CM-33714 with DCT, NCI, NIH
Rights and permissions
About this article
Cite this article
De Lena, M., Zucali, R., Viganotti, G. et al. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother. Pharmacol. 1, 53–59 (1978). https://doi.org/10.1007/BF00253147
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00253147